Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
Price Target
Average
102.92%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
26.33%
Net Income
Estimate
28.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
KalVista Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for KALV of $22.7 , with forecasts ranging from
a
low of
$20 to a high of $28 .
KALV Lowest Price Target
Wall Street Target
20 USD
79.05%
KALV Average Price Target
Wall Street Target
22.7 USD
102.92%
KALV Highest Price Target
Wall Street Target
28 USD
150.67%
REVENUE FORECAST
Revenue Forecast Chart KALV
EBIT FORECAST
EBIT Forecast Chart KALV
NET INCOME FORECAST
Net Income Chart KALV